K. Long

发表

Under-utilization of minimally invasive surgery in the management of endometrial cancer: A Healthcare Cost and Utilization Project-National Inpatient Sample study (HCUP-NIS)

Edward J. Tanner, R. Matsuno, R. Bristow, 2015 .

Hereditary ovarian cancer: recent molecular insights and their impact on screening strategies

K. Long, N. Kauff, 2011, Current opinion in oncology.

Factors associated with successful bilateral sentinel lymph node mapping in endometrial cancer.

A. Fader, A. Sinno, E. Tanner, 2015, Gynecologic oncology.

Prophylactic salpingectomy in premenopausal women at low risk for ovarian cancer: risk-reducing or risky?

A. Fader, E. Tanner, K. Long, 2013, Fertility and sterility.

Ventral hernia following primary laparotomy for ovarian, fallopian tube, and primary peritoneal cancers.

R. Barakat, D. Chi, K. Long, 2011, Gynecologic oncology.

Parenchymal splenic metastasis is an independent negative predictor of overall survival in advanced ovarian, fallopian tube, and primary peritoneal cancer.

R. Barakat, D. Chi, E. Tanner, 2012, Gynecologic oncology.

Intraoperative hypothermia during primary surgical cytoreduction for advanced ovarian cancer: risk factors and associations with postoperative morbidity.

D. Levine, R. Barakat, D. Chi, 2013, Gynecologic oncology.

Fertility considerations in the management of gynecologic malignancies.

K. Long, N. Abu-Rustum, N. Noyes, 2011, Gynecologic oncology.

Management of patients with early-stage ovarian clear cell carcinoma: risk stratification and fertility conservation

B. Weigelt, D. Chi, A. Iasonos, 2022, International Journal of Gynecological Cancer.

Screening for familial ovarian cancer: a ray of hope and a light to steer by.

K. Long, N. Kauff, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Optimal (≤1 cm) but visible residual disease: is extensive debulking warranted?

D. Levine, R. Barakat, D. Chi, 2013, Gynecologic oncology.

Clinical Approach to Diagnosis and Management of Cancer of the Cervix and Vulva.

K. Long, N. Abu-Rustum, 2011, Surgical pathology clinics.

Postoperative outcomes among patients undergoing thoracostomy tube placement at time of diaphragm peritonectomy or resection during primary cytoreductive surgery for ovarian cancer.

D. Levine, R. Barakat, D. Chi, 2013, Gynecologic oncology.

Preoperative patient stratification results in low rates of occult uterine malignancy in women undergoing uterine surgery and morcellation

A. Fader, A. Sinno, E. Tanner, 2015 .

Impact of operative start time on surgical outcomes in patients undergoing primary cytoreduction for advanced ovarian cancer.

R. Barakat, D. Chi, A. Iasonos, 2012, Gynecologic oncology.

Patterns of recurrence in 1988 FIGO stage IC endometrioid endometrial cancer.

R. Barakat, D. Chi, K. Long, 2012, Gynecologic oncology.

Outcomes of primary surgical cytoreduction in patients with BRCA-associated high-grade serous ovarian carcinoma.

D. Levine, D. Hyman, D. Spriggs, 2012, Gynecologic oncology.

Ovarian Cancer: Surgical Considerations

D. Chi, K. Long, 2013 .

Prognostic significance of supraclavicular lymphadenopathy in patients with high-grade serous ovarian cancer

P. Cybulska, D. Chi, K. Long, 2019, International Journal of Gynecological Cancer.

Delays from neoadjuvant chemotherapy to interval debulking surgery and survival in ovarian cancer

D. Chi, A. Iasonos, C. Aghajanian, 2020, International Journal of Gynecological Cancer.

Screening for familial ovarian cancer: a ray of hope and a light to steer by.

K. Long, N. Kauff, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.